ING vs MRSH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ING presents a stark contrast between deep value and deteriorating fundamental health. While the stock trades significantly below its Graham Number ($34.91) and Intrinsic Value ($73.16), the Piotroski F-Score of 2/9 indicates weak financial health and operational deterioration. Despite anomalous YoY growth figures and a strong dividend profile, the bearish technical trend (0/100) and low insider sentiment suggest caution. The valuation is attractive, but the fundamental health score acts as a significant drag on a bullish rating.
MRSH demonstrates stable operational health with a Piotroski F-Score of 6/9 and a strong ROE of 27.57%, yet it trades at a massive premium to its Graham Number ($73.7) and Intrinsic Value ($55.93). While the company has an exceptional 25-quarter track record of beating earnings estimates, recent YoY earnings growth has contracted by 15.4%. Bearish insider activity, specifically from the CEO, and a 0/100 technical trend suggest significant short-term headwinds despite a 'Buy' analyst consensus. The stock is a high-quality business currently suffering from a valuation disconnect and decelerating earnings momentum.
Compare Another Pair
Related Comparisons
ING vs MRSH: Head-to-Head Comparison
This page compares ING Groep N.V. (ING) and Marsh & McLennan Companies, Inc. (MRSH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.